Outcomes of endovascular interventions for salvage of renal transplant allografts Shipra Arya, MD, SM, Dawn M. Coleman, MD, Nicholas H. Osborne, MD, MS, Michael Englesbe, MD, Eva Rzucidlo, MD, Peter K. Henke, MD, John E. Rectenwald, MD, MS, Katherine A. Gallagher, MD Journal of Vascular Surgery Volume 57, Issue 6, Pages 1621-1627 (June 2013) DOI: 10.1016/j.jvs.2012.11.117 Copyright © 2013 Society for Vascular Surgery Terms and Conditions
Fig 1 Algorithm for assessment of declining transplant allograft function. ACE-I, Angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CT, computed tomography; HTN, hypertension; MRI, magnetic resonance imaging. Journal of Vascular Surgery 2013 57, 1621-1627DOI: (10.1016/j.jvs.2012.11.117) Copyright © 2013 Society for Vascular Surgery Terms and Conditions
Fig 2 Renal transplant allograft survival by primary indication of endovascular intervention: worsening renal function (renalFxn), renovascular hypertension (HTN), or structural anomalies. Journal of Vascular Surgery 2013 57, 1621-1627DOI: (10.1016/j.jvs.2012.11.117) Copyright © 2013 Society for Vascular Surgery Terms and Conditions
Fig 3 Renal transplant allograft survival by presence of renovascular hypertension (HTN) at the time of the initial endovascular intervention. Journal of Vascular Surgery 2013 57, 1621-1627DOI: (10.1016/j.jvs.2012.11.117) Copyright © 2013 Society for Vascular Surgery Terms and Conditions